Results
eNauka >
Rezultati >
Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer
| Naziv: | Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer | Autori: | Van, Cutsem Eric; Hidalgo, Manuel; Canon, Jean-Luc; Macarulla, Teresa; Bazin, Igor; Poddubskaya, Elena; Manojlović, Nebojša S.   ; Radenkovic, Dejan V; Verslype, Chris; Eric, Raymond; |
Godina: | 2018 | Publikacija: | INTERNATIONAL JOURNAL OF CANCER | ISSN: | 0020-7136 e1097-0215 International Journal of Cancer Pretraži identifikator |
Izdavač: | Wiley | Tip rezultata: | Naučni članak | Kolacija: | vol. 143 br. 8 str. 2053-2064 | DOI: | 10.1002/ijc.31603 | WoS-ID: | 000443942800022 | Scopus-ID: | 2-s2.0-85051645817 | URI: | https://enauka.gov.rs/handle/123456789/812938 | URL: | https://ezproxy.nb.rs:2062/doi/pdf/10.1002/ijc.31603 | Projekat: | Merck KGaA, Darmstadt, Germany [NCT01016483] EMD Serono, Inc. [NCT01016483] |
Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | 21aM21a - Vodeći međunarodni časopis kategorije M21a |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.